USANA Health Sciences Inc. (NYSE:USNA) major shareholder Global Ltd Gull sold 10,000 shares of the company’s stock in a transaction dated Wednesday, October 12th. The stock was sold at an average price of $146.35, for a total transaction of $1,463,500.00. Following the completion of the sale, the insider now directly owns 6,319,110 shares of the company’s stock, valued at approximately $924,801,748.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Global Ltd Gull also recently made the following trade(s):

  • On Wednesday, September 14th, Global Ltd Gull sold 10,000 shares of USANA Health Sciences stock. The stock was sold at an average price of $134.67, for a total transaction of $1,346,700.00.
  • On Wednesday, August 10th, Global Ltd Gull sold 10,000 shares of USANA Health Sciences stock. The stock was sold at an average price of $135.08, for a total transaction of $1,350,800.00.

Shares of USANA Health Sciences Inc. (NYSE:USNA) opened at 147.15 on Monday. The firm has a 50-day moving average of $139.19 and a 200 day moving average of $127.47. The company has a market capitalization of $1.77 billion, a PE ratio of 19.40 and a beta of 1.34. USANA Health Sciences Inc. has a 12 month low of $92.00 and a 12 month high of $150.00.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings data on Tuesday, July 26th. The company reported $2.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.05 by $0.02. USANA Health Sciences had a return on equity of 34.15% and a net margin of 10.07%. The firm earned $258.50 million during the quarter, compared to analyst estimates of $256.66 million. During the same period in the prior year, the company posted $1.92 earnings per share. The business’s revenue for the quarter was up 10.8% compared to the same quarter last year. On average, equities research analysts expect that USANA Health Sciences Inc. will post $8.10 earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in USNA. Legal & General Group Plc raised its position in USANA Health Sciences by 30.9% in the second quarter. Legal & General Group Plc now owns 1,696 shares of the company’s stock valued at $186,000 after buying an additional 400 shares in the last quarter. Quadrature Capital Ltd bought a new position in USANA Health Sciences during the second quarter valued at about $242,000. BlackRock Inc. raised its position in USANA Health Sciences by 467.7% in the second quarter. BlackRock Inc. now owns 2,447 shares of the company’s stock valued at $273,000 after buying an additional 2,016 shares in the last quarter. Trexquant Investment LP bought a new position in USANA Health Sciences during the second quarter valued at about $299,000. Finally, Cubist Systematic Strategies LLC bought a new position in USANA Health Sciences during the second quarter valued at about $305,000. Hedge funds and other institutional investors own 41.85% of the company’s stock.

Several research firms recently weighed in on USNA. DA Davidson upped their price objective on shares of USANA Health Sciences from $135.00 to $150.00 and gave the stock a “neutral” rating in a report on Thursday, July 28th. Zacks Investment Research upgraded shares of USANA Health Sciences from a “hold” rating to a “strong-buy” rating and set a $158.00 price target on the stock in a research report on Saturday, July 30th.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. It operates as a direct selling company in approximately two geographic regions: Americas and Europe, and Asia Pacific, which includes approximately three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

5 Day Chart for NYSE:USNA

Receive News & Stock Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related stocks with our FREE daily email newsletter.